Ethical Lifespan Enhancement. (360G-Wellcome-094604_Z_10_Z)

£169,009

Current medical and policy strategies have doubled our lifespans over the past century, with a number of corresponding benefits to individuals and societies. However, the cost of these strategies has been a progressive loss of wellbeing amongst the very old, along with a rapid increase in the distributed burdens of aged care. The first goal of this research is to reframe our existing medical structures in terms of life extension instead of life saving, in order to evaluate the success of existin g policies within this framework. We are now approaching a technological inflection point which will lead to further radical improvements in lifespan, not only in terms of average life expectancy but also maximum lifespan. The new therapies are designed for life extension from the ground up. The second goal is to make an ethical assessment of these impending technologies. The third goal is to compare the new and existing life-extension strategies to determine which is the most beneficent a nd which is the most just. It will provide guidance on the best regulatory models for obtaining the benefits of these technologies while minimizing economic costs, unjust inequalities and harmful changes to demographics and lifestyle.

Where is this data from?

This data was originally published by The Wellcome Trust. If you need to report a problem in the data please contact The Wellcome Trust directly, see their GrantNav publisher page for more information.

Grant Details

Amount Awarded 169009
Applicant Surname Foddy
Approval Committee Biomedical Ethics Interview Committee
Award Date 2010-11-18T00:00:00+00:00
Financial Year 2010/11
Grant Programme: Title Research Fellowship in H&SS
Internal ID 094604/Z/10/Z
Lead Applicant Dr Bennett Foddy
Partnership Value 169009
Planned Dates: End Date 2013-09-17T00:00:00+00:00
Planned Dates: Start Date 2011-05-18T00:00:00+00:00
Recipient Org: Country United Kingdom
Region South East
Sponsor(s) Prof Julian Savulescu